» Articles » PMID: 25408545

BDNF Repairs Podocyte Damage by MicroRNA-mediated Increase of Actin Polymerization

Abstract

Idiopathic focal segmental glomerulosclerosis (FSGS) is a progressive and proteinuric kidney disease that starts with podocyte injury. Podocytes cover the external side of the glomerular capillary by a complex web of primary and secondary ramifications. Similar to dendritic spines of neuronal cells, podocyte processes rely on a dynamic actin-based cytoskeletal architecture to maintain shape and function. Brain-derived neurotrophic factor (BDNF) is a pleiotropic neurotrophin that binds to the tropomyosin-related kinase B receptor (TrkB) and has crucial roles in neuron maturation, survival, and activity. In neuronal cultures, exogenously added BDNF increases the number and size of dendritic spines. In animal models, BDNF administration is beneficial in both central and peripheral nervous system disorders. Here we show that BDNF has a TrkB-dependent trophic activity on podocyte cell processes; by affecting microRNA-134 and microRNA-132 signalling, BDNF up-regulates Limk1 translation and phosphorylation, and increases cofilin phosphorylation, which results in actin polymerization. Importantly, BDNF effectively repairs podocyte damage in vitro, and contrasts proteinuria and glomerular lesions in in vivo models of FSGS, opening a potential new perspective to the treatment of podocyte disorders.

Citing Articles

Exosomes with Engineered Brain Derived Neurotrophic Factor on Their Surfaces Can Proliferate Menstrual Blood Derived Mesenchymal Stem Cells: Targeted Delivery for a Protein Drug.

Gorji F, Mahdavian S, Khodashenas S, Kiasari Z, Valadan R, Khalili S Protein J. 2024; 43(6):1070-1082.

PMID: 39397145 DOI: 10.1007/s10930-024-10234-9.


Low brain-derived neurotrophic factor and high vascular cell adhesion molecule-1 levels are associated with chronic kidney disease in patients with type 2 diabetes mellitus.

Chiang Y, Li Y, Chan Y, Cheng Y, Wu J, Lin J Front Endocrinol (Lausanne). 2024; 15:1403717.

PMID: 39355615 PMC: 11442372. DOI: 10.3389/fendo.2024.1403717.


Assessment of brain-derived neurotrophic factor and irisin concentration in children with chronic kidney disease: a pilot study.

Gliwinska A, Badenska M, Dworak M, Swietochowska E, Badenski A, Bjanid O BMC Nephrol. 2024; 25(1):318.

PMID: 39334009 PMC: 11430335. DOI: 10.1186/s12882-024-03767-9.


BDNF Modulation by microRNAs: An Update on the Evidence.

De Assis G, Murawska-Cialowicz E Cells. 2024; 13(10.

PMID: 38786102 PMC: 11119608. DOI: 10.3390/cells13100880.


Neurotrophin-4 and Brain-Derived Neurotrophic Factor Serum Levels in Renal Transplant Recipients with Chronic Pruritus.

Tyczynska K, Krajewski P, Nowicka-Suszko D, Janczak D, Augustyniak-Bartosik H, Krajewska M Dermatol Ther (Heidelb). 2023; 13(11):2785-2796.

PMID: 37779167 PMC: 10613176. DOI: 10.1007/s13555-023-01029-4.


References
1.
de Girolamo P, Arcamone N, Lucini C, Castaldo L, Vega J, Gargiulo G . The teleost kidney expresses Trk neurotrophin receptor-like proteins. Anat Embryol (Berl). 2000; 201(5):429-33. DOI: 10.1007/s004290050330. View

2.
Zennaro C, Mariotti M, Carraro M, Pasqualetti S, Corbelli A, Armelloni S . Podocyte developmental defects caused by adriamycin in zebrafish embryos and larvae: a novel model of glomerular damage. PLoS One. 2014; 9(5):e98131. PMC: 4028291. DOI: 10.1371/journal.pone.0098131. View

3.
Tyler W . BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses. J Neurosci. 2001; 21(12):4249-58. PMC: 2806848. View

4.
Meng Y, Zhang Y, Tregoubov V, Janus C, Cruz L, Jackson M . Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. Neuron. 2002; 35(1):121-33. DOI: 10.1016/s0896-6273(02)00758-4. View

5.
Jin X, Hu H, Mathers P, Agmon A . Brain-derived neurotrophic factor mediates activity-dependent dendritic growth in nonpyramidal neocortical interneurons in developing organotypic cultures. J Neurosci. 2003; 23(13):5662-73. PMC: 6741232. View